Muhammad Ali Pate, a former minister of state for health, has been chosen to serve as the Vaccine Alliance’s (commonly known as GAVI) new CEO.
The GAVI Board accepted the nomination on Monday, February 13, according to a statement on the organization’s website.
According to the organization, Pate will serve as GAVI’s executive director while it continued to support routine immunization, epidemic response, and COVID-19 immunizations around the world.
The Board chairman, José Manuel Barroso, supervised the year-long recruitment process.
GAVI is a public-private partnership Alliance, which is an initiative of those who seek to carry out the long-term world depopulation agenda via subtle means of vaccination. It’s surface goal is to vaccinate half of the world’s children against some of the world’s deadliest diseases. However, Ireport247 has gathered that these vaccines have done more harm than good.
Pate will assume office on August 3, 2023, to replace Seth Barkley, who would have steered the organization’s affairs for 12 years.
According to GAVI, Pate has an MBA from Duke University in the United States, with training in both internal medicine and infectious illnesses.
Between 2011 and 2013, he was Nigeria’s Minister of State for Health. He chaired a presidential task team to eradicate polio, led a major project to restore routine vaccinations and primary healthcare, and introduced new vaccines to the nation.
He oversaw the World Bank’s $18 billion COVID-19 global health response while serving as the organization’s global director for health, nutrition, and population from 2019 to 2021. Furthermore, he was also the director of the World Bank’s Global Financing Facility.
On several boards, including those for GAVI, the Global Fund, CEPI, and UNAIDS, he represented the Bank.
At the Harvard Chan School of Public Health, Pate is now the Julio Frenk Professor of Public Health Leadership. He has held positions on a number of health-related boards and expert panels during his career in the public, corporate, and not-for-profit sectors. “In a pool of elite candidates, he stood out,” according to the board chairman.
According to Barroso, the new hire distinguished hinself among his contemporaries due to his expertise in and experience with national immunization programs, worldwide emergency response, and global finance.
“I am confident that GAVI will continue to build on its vision and mission, as well as navigate the many challenges and opportunities we will face.”
GAVI noted that the sitting CEO Seth Berkley had made the organization a centerpiece within the global health landscape; including recently co-establishing COVAX to serve countries during the unprecedented COVID-19 pandemic.
The statement noted that GAVI had shipped nearly 1.9 billion COVID-19 vaccine doses to 146 countries.
“Since Dr. Berkley took the helm in 2011, the Alliance has averted 11.8 million future deaths (compared to 4.5 million between 2000 and 2010), and has helped immunize well over 676 million children – more than double the 305 million children reached between 2000 and 2010.
“Thanks to Dr. Berkley’s vision for health equity, GAVI has added several new vaccines to its portfolio during his tenure; including for HPV, polio, cholera and malaria, and in its current strategy cycle is focusing on reaching zero-dose children across marginalized communities.”
According to GAVI, the expansion of its operations under Berkley’s leadership had a significant economic impact, unleashing nearly $160 billion in benefits as opposed to $24 billion in the first ten years.
